Cargando…

The Clinical Significance and Utility of Routine Screening for Macroprolactin in Patients With Hyperprolactinemia

Background: Macroprolactin is a complex of monomeric prolactin (PRL) molecules with immunoglobulin G (IgG) that can result in the elevation of serum prolactin level. Macroprolactin is biologically less active and failure to screen for macroprolactin may lead to unnecessary investigations and treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Wanling, James King, Thomas Frederick, Aw, Tar Choon, Shern Lau, Michael Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090549/ http://dx.doi.org/10.1210/jendso/bvab048.1295

Ejemplares similares

SAT-456 Heterogeneity of Macroprolactin in Samples Suspected of False Hyperprolactinemia
por: Nguyen, Khanh Quynh, et al.
Publicado: (2019)

Macroprolactin Molecular Heterogeneity and Variable Immunoassay Reactivity
por: Hashim, Ibrahim A, et al.
Publicado: (2021)

FRI314 Prolactinoma And Macroprolactin; A Diagnostic Dilemma
por: Farooqi, Aneeba, et al.
Publicado: (2023)

Drug Induced Hyperprolactinemia
por: Venkatanarasu, Ashok, et al.
Publicado: (2021)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Acute Ischaemic Stroke With Hyperprolactinemia:A Case Report
por: Wan Zain, Wan Mohd Saifuhisam, et al.
Publicado: (2021)

SAT-479 Hyperprolactinemia in a Patient with Multiple Possible Causes
por: Hosein, Rachael, et al.
Publicado: (2019)

FRI315 Hyperprolactinemia In The Presence Of Severe Calorie Restriction And Stress
por: Alrasheed, Tariq, et al.
Publicado: (2023)

SAT-476 A Case of Rathke's Cleft Cyst Presenting with Hyperprolactinemia
por: Tsushima, Yumiko, et al.
Publicado: (2019)

MON-258 Hyperprolactinemia: An Unusual Initial Presenting Manifestation of Multiple Sclerosis
por: Hodge, MaKenzie, et al.
Publicado: (2020)

MON-282 Treatment of Hyperprolactinemia with Ropinirole: An Open-Label Dose Escalation Study
por: Tsang, Amanda, et al.
Publicado: (2020)

MON-427 An Interesting Case of Drug-Induced Hyperprolactinemia in a Patient Who Presented with Psychosis
por: Siddiqi, Asmat, et al.
Publicado: (2019)

MON-275 Prolactin to Testosterone Ratio Predicts Pituitary Pathology in Hypogonadal Men with Mild Hyperprolactinemia
por: Naelitz, Bryan D, et al.
Publicado: (2020)

THU091 Hypopituitarism And The Finding Of Hyperprolactinemia Following Mild Traumatic Brain Injury In Female Athletes
por: Claessen, Lára Ósk Eggertsdóttir, et al.
Publicado: (2023)

FRI297 Hemoglobin Decline As A Signal For Hyperprolactinemia Onset Prior To Prolactinoma Diagnosis In Hypogonadal Men
por: Rudman, Yaron, et al.
Publicado: (2023)

OR2806 Levosulpiride-Induced Hyperprolactinemia For The Treatment Of Diabetic Macular Edema: A Phase 2 Pilot Clinical Trial
por: Clapp, Carmen, et al.
Publicado: (2023)

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019)

PMON125 A Case of Hypothalamic Lipoma Causing Hyperprolactinemia in a Patient With Family History of Birt-Hogg-Dubé Syndrome
por: Branis, Natalia, et al.
Publicado: (2022)

Macroprolactin; A Frequent Cause of Misdiagnosed Hyperprolactinemia in Clinical Practice
por: Vaishya, Richa, et al.
Publicado: (2010)

MON-LB069 When a Routine Postoperative Internal Medicine Consultation Unearths a Hidden Diagnosis
por: Chengappa, Madhuri, et al.
Publicado: (2019)

SAT-434 Patient Reported Outcome Data from Acromegaly Patients Treated with Injectable Somatostatin Analogues in Routine Clinical Practice: Preliminary Results
por: Geer, Eliza, et al.
Publicado: (2019)

OR23-01 Intrapatient ACTH Variability in Cushing’s Disease: Prognostic Significance
por: Alvarez, Reinier, et al.
Publicado: (2020)

SUN-272 Significant Response to Temozolomide in Two Aggressively Growing Pituitary Adenomas
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combination Checkpoint Inhibitors
por: Galligan, Anna, et al.
Publicado: (2020)

PMON102 Utility of the Desmopressin Stimulation Test to Detect Cyclic Cushing's Disease
por: Elenius, Henrik, et al.
Publicado: (2022)

SUN-296 Acromegaly Significantly Impacts Employees’ Health Benefit Costs and Increases Work Absenteeism
por: Yuen, Kevin C j, et al.
Publicado: (2020)

SUN-LB078 Biochemically Controlled Acromegaly Patients on a Stable Dose of Injectable Somatostatin Analogues in Routine Clinical Practice Still Remain Symptomatic: Preliminary Results from Endocrinology Health Care Professionals
por: Geer, Eliza, et al.
Publicado: (2019)

SUN-447 Screening of Genetic Alterations in Patients with Giant Prolactinomas
por: Chaves, Carolina, et al.
Publicado: (2019)

SUN-LB077 Relationship between Responses from Acromegaly Patients Treated with a Stable Dose of Injectable Somatostatin Analogues in Routine Clinical Practice and Their Endocrinology Health Care Professional Regarding Treatment Outcomes: Preliminary Findings
por: Geer, Eliza, et al.
Publicado: (2019)

MON-270 Diagnostic Value of Copeptin in Central Diabetes Insipidus
por: Boehm, Emma, et al.
Publicado: (2020)

MON-329 Diagnostic Utility of Overnight High Dose Dexamethasone Suppression Test for Differentiating the Etiology of ACTH Dependent Cushing’s Syndrome
por: Yadav, Subhash B, et al.
Publicado: (2020)

ODP314 Gynecomastia as the Initial Presentation of Acromegaly.
por: Lim, Frederick, et al.
Publicado: (2022)

THU119 Screening Publicly Available Data To Identify Candidate Genes For Congenital Hypopituitarism
por: Brinkmeier, Michelle L, et al.
Publicado: (2023)

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

MON-LB48 The Genomic Landscape of Sporadic Thyrotrophinomas
por: shen, Angeline, et al.
Publicado: (2020)

LBODP077 The Therapeutic Potential Of Targeting Histone Deacetylase For Pituitary Neuroendocrine Tumors By High-throughout Drug Screening
por: Wu, Zhe Bao, et al.
Publicado: (2022)

MON-457 One in Five Patients Develop Multiple Hormone Deficiencies Following Radiotherapy for Acromegaly or Cushing's Disease
por: Shen, Angeline, et al.
Publicado: (2019)

MON-284 Systematic Screening Reveals Large Number of Undiagnosed and Untreated Cardiovascular Risk Factors in Adults with Prader-Willi Syndrome
por: Pellikaan, Karlijn, et al.
Publicado: (2020)

THU048 Determination Of Receptor Binding Affinity Of Growth Hormone Analogues To The Growth Hormone Receptor In A Drug Screening Context
por: Erlendsson, Simon, et al.
Publicado: (2023)

OR27-1 11-Oxygenated C19 Steroids Are the Predominant Androgens Responsible for Hyperandrogenemia in Cushing's Disease
por: Adaway, Jo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mbnhm4c5s3f0qmso9d4c4pkhio